Method for evaluating multiple different genes of interest Grant US-11542497-B2 United States of America 03 Jan 2023
Therapeutic agent for lung cancer that has acquired EGFR-TKI resistance Grant US-11419871-B2 United States of America 23 Aug 2022
Treatment of EGFR-driven cancer with fewer side effects Grant US-11395821-B2 United States of America 26 Jul 2022
SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORS Application WO-2022090481-A1 World Intellectual Property Organisation (WIPO) 05 May 2022
Combination therapy of Axl inhibitor and EGFR tyrosine kinase inhibitor Grant US-11318124-B2 United States of America 03 May 2022
2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation method… Grant US-11267802-B2 United States of America 08 Mar 2022
Benzimidazole compounds and derivatives as EGFR inhibitors Grant US-11174245-B2 United States of America 16 Nov 2021
Bifunctional molecules for degradation of EGFR and methods of use Grant US-11161842-B2 United States of America 02 Nov 2021
METHOD FOR EVLAUATING THE EFFICACY OF COMPOSITION IN REDUCING THE EFFECTS OF CANCER… Application WO-2021123947-A1 World Intellectual Property Organisation (WIPO) 24 Jun 2021
TREATMENT OF EGFR-DRIVEN CANCER WITH FEWER SIDE EFFECTS Application EP-3585389-A4 European Patent Office 23 Dec 2020
Pyrimidines as EGFR inhibitors and methods of treating disorders Grant US-10870636-B2 United States of America 22 Dec 2020
Therapeutic agent for lung cancer that has acquired EGFR-TKI resistance Grant US-10813933-B2 United States of America 27 Oct 2020
Method for treating gefitinib resistant cancer Grant US-10596162-B2 United States of America 24 Mar 2020
Kinase inhibitor prodrug for the treatment of cancer Application US-10507210-B2 United States of America 17 Dec 2019
Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor Application US-10494373-B2 United States of America 03 Dec 2019
Bifunctional molecules for degradation of EGFR and methods of use Grant US-10450310-B2 United States of America 22 Oct 2019
Pyrimidines as EGFR inhibitors and methods of treating disorders Grant US-10266517-B2 United States of America 23 Apr 2019
Antineoplastic combinations containing HKI-272 and vinorelbine Grant US-10111868-B2 United States of America 30 Oct 2018
Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor Application US-10093656-B2 United States of America 09 Oct 2018
Maleate salts of (E)-N-{4[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinol… Grant US-10035788-B2 United States of America 31 Jul 2018
ANTICANCER COMBINATION THERAPY Application WO-2017055291-A1 World Intellectual Property Organisation (WIPO) 06 Apr 2017